Treatment With Glutathione Precursor Decreases Cytokine Activity

Abstract

Treatment with the GSH prodrug OTZ inhibited monocyte cytokine production and increased whole blood GSH. This may have important therapeutic implications for multiple cytokine-mediated disease processes.